Live feed08:00:00·4mPRReleasevia QuantisnowCEL-SCI to Launch FDA Registration-Enabling Phase 3 Confirmatory Study to Bring Multikine® to Market for Newly Diagnosed Head and Neck CancerByQuantisnow·Wall Street's wire, on your screen.CVM· Cel-Sci CorporationHealth Care
